Queen Elixir Guide: MK-677 Formula, History and Research

Queen Elixir was a discontinued branded formula positioned around Ibutamoren, better known as MK-677. It was marketed toward women interested in growth-hormone signalling, body composition, sleep and age-related changes, but many of the broad claims attached to the original product went beyond what controlled MK-677 research established.

What Was Queen Elixir?

Queen Elixir was previously sold as a women-focused formula intended to support several goals commonly associated with growth-hormone signalling and healthy ageing.

The historical product page identified Ibutamoren as its main ingredient. Ibutamoren is also known as MK-677 and MK-0677.

Queen Elixir is no longer part of the active Sarms Thailand product range. This guide remains available to explain what the product was, how its principal compound works and which claims are supported by published research.

Was Queen Elixir the Same as MK-677?

Queen Elixir was centered on MK-677, but it should not automatically be treated as identical to the current standalone MK-677 product.

The complete historical Queen Elixir formula and concentration are not being represented here as equivalent to the current product. What can be stated accurately is that the original page identified Ibutamoren as its main active ingredient.

Visitors interested specifically in Ibutamoren can now review the standalone MK-677 20 mg/ml liquid product, where the concentration, bottle size and current availability are clearly shown.

What Is MK-677 Ibutamoren?

MK-677 is an orally active growth-hormone secretagogue. It activates the growth-hormone secretagogue receptor, which is also commonly known as the ghrelin receptor.

This activity can stimulate the body’s own pulsatile release of growth hormone and increase insulin-like growth factor 1, usually abbreviated as IGF-1.

MK-677 does not supply injected growth hormone directly. It influences the signalling pathway that controls endogenous growth-hormone release.

Is MK-677 a SARM?

No. MK-677 is frequently sold alongside SARMs and included in SARM stacks, but it is not a selective androgen receptor modulator.

True SARMs such as Ostarine, LGD-4033, RAD-140 and S-4 act through androgen receptors. MK-677 instead acts through the ghrelin receptor and growth-hormone signalling system.

Queen Elixir therefore belonged to the broader performance and body-composition market rather than the SARM compound class itself.

What Human Research Found

Controlled human studies have shown that MK-677 can increase growth-hormone secretion and IGF-1 concentrations.

A short controlled study in healthy adults reported increased growth-hormone pulse activity and higher IGF-1 during MK-677 treatment. Longer research in older adults also reported sustained effects on the growth-hormone and IGF-1 system.

These findings support the conclusion that MK-677 has measurable biological activity in humans. They do not confirm every benefit previously attributed to Queen Elixir.

MK-677 and Fat-Free Mass

A randomized study lasting approximately one year examined MK-677 in healthy adults between 60 and 81 years old.

The researchers reported an increase in fat-free mass compared with placebo. However, the study did not find a corresponding significant improvement in strength or physical function.

Fat-free mass includes muscle as well as water, connective tissue and other non-fat components. It should not automatically be interpreted as an equal increase in visible muscle tissue.

Does MK-677 Produce Weight Loss?

MK-677 should not be presented as a direct weight-loss or fat-burning compound.

In the longer study of older adults, total fat mass and abdominal visceral fat did not decrease significantly. MK-677 can also influence appetite because it activates the ghrelin receptor.

Changes in body weight and body fat remain strongly influenced by calorie intake, nutrition, activity and training.

MK-677 and Sleep Research

Small controlled studies have investigated MK-677’s effect on sleep architecture.

Researchers reported changes in rapid-eye-movement sleep and deeper slow-wave sleep during treatment. These findings contributed to the interest in MK-677 for sleep and recovery.

The evidence does not establish that every person will sleep better or that MK-677 is an approved treatment for insomnia or another sleep disorder.

MK-677 and Skin, Hair and Anti-Ageing Claims

The previous Queen Elixir page made wide-ranging claims involving tighter skin, fewer wrinkles, thicker hair, restored hair colour, improved vision, stronger nails and reversal of age-related changes.

Controlled MK-677 studies did not establish this complete list of outcomes. Research showing increased growth hormone or IGF-1 cannot by itself prove that a product reverses grey hair, regrows lost hair, removes wrinkles or restores youthful skin.

These older promotional claims have therefore been removed from the updated guide.

MK-677 and Energy, Mood and Mental Clarity

The original Queen Elixir description also promised improvements in energy, mood, concentration, memory and general wellbeing.

Individual users may describe subjective changes, but these outcomes were not consistently established as guaranteed effects in controlled MK-677 trials.

Changes in sleep, appetite, training, nutrition and expectations can also affect how energy and wellbeing are perceived.

MK-677 and Bone Research

Growth hormone and IGF-1 have biological roles in bone metabolism, which led to research interest in growth-hormone secretagogues for age-related conditions.

This does not mean that Queen Elixir or MK-677 has been proven to prevent osteoporosis, heal fractures or replace established medical treatment.

Claims involving diagnosed bone disease require evidence from appropriate clinical trials rather than relying only on changes in hormone measurements.

Blood Glucose and Insulin Sensitivity

MK-677 research has also identified effects on glucose metabolism.

In the twelve-month study of older adults, fasting glucose increased and insulin sensitivity declined during treatment. These findings are an important part of the compound’s research profile.

The old Queen Elixir page focused heavily on potential benefits but did not adequately explain that increasing growth-hormone signalling may also affect metabolic measurements.

Is MK-677 a Hormone-Replacement Therapy?

No. MK-677 is not the same as prescribed growth-hormone replacement therapy.

Growth-hormone replacement involves administering growth hormone under medical supervision for specific diagnosed conditions. MK-677 is an investigational secretagogue that stimulates endogenous growth-hormone release through the ghrelin receptor.

The original Queen Elixir page incorrectly blended these concepts and used research involving hormone replacement to support a separate investigational compound.

Why Queen Elixir Is No Longer Sold

Queen Elixir is no longer stocked as a separate branded product by Sarms Thailand.

Keeping this informational page allows previous customers and people searching for the old name to understand that its main identified compound was MK-677 Ibutamoren.

Visitors interested in that compound can now review it directly without the broader Queen Elixir branding or unsupported beauty and anti-ageing promises.

Queen Elixir Compared With Standalone MK-677

Queen Elixir was a branded product concept aimed primarily at women and age-related wellness searches.

The current MK-677 listing is a straightforward single-compound product page. It identifies the compound, concentration, bottle size, research class and current availability without presenting it as a beauty or anti-ageing formula.

The standalone product is therefore the more transparent option for visitors specifically looking for Ibutamoren.

Queen Elixir Compared With True SARMs

Queen Elixir’s main identified compound worked through growth-hormone and ghrelin-receptor signalling rather than androgen receptors.

It should not be directly compared with Ostarine, LGD-4033 or RAD-140 simply because all of these products were historically sold within the same category.

Current androgen-receptor compounds can be compared through the Liquid SARMs in Thailand category, while detailed Ibutamoren research is covered in the MK-677 Ibutamoren guide.

Queen Elixir Research Status

Queen Elixir itself was a commercial branded formula rather than the subject of a published clinical-development program.

The relevant research relates to MK-677 Ibutamoren, not to the Queen Elixir brand as a complete finished product.

MK-677 remains investigational and is not approved as a general anti-ageing, weight-loss, beauty, muscle-building or athletic-performance medicine.

Frequently Asked Questions

What was the main ingredient in Queen Elixir?

The original Queen Elixir page identified Ibutamoren, also known as MK-677, as its main ingredient.

Can I still buy Queen Elixir?

No. Queen Elixir is no longer stocked by Sarms Thailand.

Can I buy MK-677 separately?

Yes. The main compound associated with Queen Elixir is available through the standalone MK-677 Ibutamoren product page. Current availability is displayed on that page.

Is Queen Elixir a SARM?

Its main identified compound, MK-677, is not a SARM. It is a growth-hormone secretagogue and ghrelin-receptor agonist.

Was Queen Elixir proven to reverse ageing?

No. Controlled research did not establish that Queen Elixir reversed ageing, restored youthful hair colour, removed wrinkles or prevented the broad range of diseases claimed on the old page.

Does MK-677 increase growth hormone?

Controlled human studies have reported increased pulsatile growth-hormone secretion and higher IGF-1 concentrations during MK-677 treatment.

Does MK-677 produce fat loss?

It has not been established as a direct fat-loss compound. Longer controlled research did not report significant reductions in total or abdominal fat.

Is the current MK-677 product identical to Queen Elixir?

No claim is being made that the historical Queen Elixir formula is identical to the current standalone product. The old page identified Ibutamoren as Queen Elixir’s main ingredient, while the current listing clearly provides standalone MK-677 at 20 mg per ml.

MK-677 Research Sources

• Twelve-month randomized MK-677 study in healthy older adults
• Controlled study of MK-677, growth hormone and IGF-1
• MK-677 research during calorie restriction and nitrogen loss
• Controlled MK-677 sleep research
• Two-month MK-677 study in obese men
• PubChem information for Ibutamoren